Codea Andrei Răzvan, Popa Romeo, Sevastre Bogdan, Biriș Alexandra, Neagu Daniela, Popovici Cristian, Mircean Mircea, Ober Ciprian
Department of Internal Medicine, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania.
Department of Pharmacology, University of Medicine and Pharmacy, 200349 Craiova, Romania.
Life (Basel). 2024 Jul 11;14(7):867. doi: 10.3390/life14070867.
Ultrasound-guided kidney biopsy is an essential diagnostics method that can increase the accuracy of the differential diagnosis between acute and chronic nephropathies. In addition, it will help clinicians perform an etiologic diagnosis, issue a prognosis, and orient therapy for the majority of parenchymal nephropathies. Due to the relative invasiveness and potential adverse effects, the use of kidney biopsies is limited among practitioners.
Twenty-eight dogs, of mixed breed and variable ages, of which 11 (39, 29%) were males and 17 (60, 71%) were females, were examined and underwent an ultrasound-guided kidney biopsy to establish a definitive diagnosis. The patients were presented with a variety of diffuse nephropathies, such as kidney lymphoma: 1 (3.57%), glomerulonephritis: 13 (46.43%), tubulointerstitial nephritis: 11 (39.29%), and nephrocalcinosis. A total of 3 (10.71%) of 18 (64.29%) were in acute kidney injury, and 10 (35.71%) were CKD patients. The type and the severity of the kidney lesions were correlated with changes in the urinary n-acetyl-beta-d-glucosaminidase index (iNAG. To quantify the side effects of percutaneous kidney biopsy, the magnitude of post-biopsy hematuria and changes in urinary iNAG activity were evaluated. The results indicate a significant post-biopsy increase in the urinary iNAG activity in all the patients that underwent this procedure (100.08 ± 34.45 U/g), with a pre-biopsy iNAG vs. 147.65 ± 33.26 U/g post-biopsy iNAG ( < 0.001), suggesting an intensification in the kidney tubular damage that comes consecutives to kidney puncture and sampling. Transitory macro- or microhematuria were constant findings in all the dogs that underwent ultrasound-guided kidney biopsy, but the magnitude and extent could not be associated with the platelet count (PLT 109/L), aPTT (s), and PT (s) levels in our patients, and they were also resolved after 12-24 h without therapeutic interventions.
Ultrasound-guided renal biopsy was shown to be a minimally invasive diagnostic procedure that causes transient and limited effects on kidney structures. Although these effects were minor and resolved without intervention, we feel that the benefit of obtaining higher-quality biopsied tissue outweighs the higher risks associated with this procedure.
超声引导下肾活检是一种重要的诊断方法,可提高急性和慢性肾病鉴别诊断的准确性。此外,它有助于临床医生对大多数实质性肾病进行病因诊断、判断预后并指导治疗。由于具有相对侵入性和潜在不良反应,肾活检在临床医生中的应用受到限制。
对28只不同品种、年龄各异的犬进行了检查,并接受了超声引导下肾活检以明确诊断,其中11只(39.29%)为雄性,17只(60.71%)为雌性。这些患者患有多种弥漫性肾病,如肾淋巴瘤:1只(3.57%)、肾小球肾炎:13只(46.43%)、肾小管间质性肾炎:11只(39.29%)以及肾钙质沉着症。18只(64.29%)中有3只(10.71%)处于急性肾损伤,10只(35.71%)为慢性肾病患者。肾损伤的类型和严重程度与尿N-乙酰-β-D-氨基葡萄糖苷酶指数(iNAG)的变化相关。为了量化经皮肾活检的副作用,评估了活检后血尿的程度以及尿iNAG活性的变化。结果表明,所有接受该手术的患者活检后尿iNAG活性均显著增加(100.08±34.45 U/g),活检前iNAG为147.65±33.26 U/g,活检后iNAG为147.65±33.26 U/g(<0.001),这表明肾穿刺和采样后肾小管损伤加剧。在所有接受超声引导下肾活检的犬中,均持续出现短暂的肉眼或镜下血尿,但血尿的程度和范围与患者的血小板计数(PLT 109/L)、活化部分凝血活酶时间(aPTT,秒)和凝血酶原时间(PT,秒)水平无关,且在未进行治疗干预的情况下,12 - 24小时后血尿也会消失。
超声引导下肾活检是一种微创诊断方法,对肾脏结构造成的影响短暂且有限。尽管这些影响较小且无需干预即可恢复,但我们认为获取更高质量活检组织的益处超过了该手术相关的较高风险。